FDA Finds Bits Of Steel, Rubber In Genzyme Drugs
BOSTON — Officials with the Food and Drug Administration said bits of steel, rubber and fiber have been found in drugs made by Cambridge-based biotechnology company Genzyme.
Four of the five drugs found to be contaminated are ones used to treat rare enzyme disorders; the other is used for thyroid imaging. All were manufactured or finished at Genzyme’s Allston Landing manufacturing plant. This contamination is separate from a viral contamination reported over the summer.

Genzyme's Allston manufacturing facility. (AP)
The drugs are not being recalled, because they are complex medications made in such small batches that patients with the disorders would be too compromised, said Jason Woo, associate director for medical and scientific affairs in the office of compliance at the FDA’s Center for Drug Evaluation and Research.
“These are products that are medically necessary for unique populations,” he said. ” Because of that, we are trying to work with the firm to assure that product remains available within a reasonable risk-benefit profile.”
FDA officials said no patients have been affected by the contamination. However, FDA doctors said among the more serious reactions that could occur are damage to blood vessels, anaphylactic reactions or blood clots.
“These are possible, but none that we’ve directly had reports of occuring,” said Julie Beitz, director of the Office of Drug Evaluation and the Center for Drug Evaluation and Research at the FDA.
The drugs are typically administered by doctors, either by intramuscular injection or intravenously. Doctors are being warned to do a visual inspection of the drug first and if it appears clear to run it through a filter before administering it.
The FDA said Genzyme first alerted regulators about the debris in May, but that the problem has now risen to the level that healthcare providers have to be notified.
“It appears that Genzyme feels that the problem is large enough to warrant that this additional information be provided to healthcare providers,” Woo said.
But Geoffrey McDonough, Genzyme’s senior vice president and general manager, genetic diseases business unit, said particles are a typical byproduct of manufacturing injectible drugs, and that the company has not seen an increase in the number of vials discovered with particles.
Instead, he said the company alerted the FDA and healthcare providers for three reasons.
“The industry at large is working to create a consensus view of what level of these particles is and should be considered acceptable, ” he said. “Second, the FDA has had several cases in the last few months of manufacturers who have issued recalls for issues in this range… so I think the FDA of course in their own way is bringing this issue to the forefront of their attention.”
He added, “Finally… we’re in the process of restarting and bringing back online this very large facility in Allston and the FDA is completing about three weeks of inspection in that facility… so I think it’s just a combination of these three things that have brought this issue into focus.”
Part of the company’s Allston plant has been shut down since the summer, when a virus contaminated the facility. That contamination led Genzyme to shut down its plant temporarily. McDonough said the plant is almost done being brought back online.
- Beacon Hill »
- Mass. House Orders Staff, Not Member, Furloughs
- Mass. Artists, Lawmakers Meet To Discuss Creative Economy
- Patrick Rebuffed In Request For Education Bill Action
- Commentary »
- Soccer Championship Has Star Power On Its Side
- At 45, Caught Between Mammograms
- The Everlasting Allure Of The World Series
- Crime & Justice »
- 5th Arrest Announced In Mont Vernon Case
- Attorney: Mehanna Arrested After Refusing To Be FBI Informant
- Review: Police Not Responsible For Celtic Fan’s Death
- Energy »
- Evergreen To China Shows It’s Not So Easy To Be Green In Mass.
- Mass. Commission Ruling Means Delay For Cape Wind
- Harvard To Buy Power From Maine Wind Farm
- Environment »
- Evergreen To China Shows It’s Not So Easy To Be Green In Mass.
- Senate Democrats Advance Climate Bill Without GOP
- Harvard To Buy Power From Maine Wind Farm
- Ethics »
- DiMasi, Co-Defendants Plead Not Guilty To Corruption
- Former Speaker DiMasi To Also Face Extortion Charge
- Amid Confusion, State Lawmakers Postpone Tougher Lobbying Law
- Religion »
- Jesuit Educator Thomas O’Malley Dies In Boston
- Vatican Creates New Structure For Anglicans
- Remembering A Different Boston, 30 Years After Pope’s Historic Visit
- Sprint To The Senate »
- Friday Morning Roundup
- Pagliuca Tries To Capitalize On Apparent Health Care Rift
- Pagliuca Tries To Set Himself Apart On Health Care
- H1N1 Swine Flu »
- FAQ: Swine Flu Facts And Figures
- Flu Now At Historic High in Mass.
- ‘Free Shevaun’: The Challenges Of Controlling Swine Flu On College Campuses
- Flu Now At Historic High in Mass.
- Picking Locks For Sport, Not Sabotage
- Does Boston Have Room For More Ice Cream?
- FAQ: Swine Flu Facts And Figures
- Sen. Kerry’s Daughter Arrested On DUI Charge
- Boston Man Dies From Swine Flu
- Boston Unveils Five-Year School Restructuring Plan
- At 45, Caught Between Mammograms
- Somali Pirates Attack Maersk Alabama A Second Time
- Mystery Blogger Keeps Close Eye On Senate Race
- Flu Now At Historic High in Mass.
- Study: No Cost Savings With Electronic Medical Records
- Boston Unveils Five-Year School Restructuring Plan
- Boston Unveils School Restructuring Plan
- Mass. Unemployment Fund Running Out Of Money
- Joshua Kosman, Predicting The Next Credit Crisis
- Picking Locks For Sport, Not Sabotage
- Flood Of Immigrants To Long Island Sparks Tension
- Sounds During Sleep May Help You Remember
- Does Boston Have Room For More Ice Cream?
- At 45, Caught Between Mammograms
- Exclusive First Listen: Norah Jones
- Joshua Kosman, Predicting The Next Credit Crisis
- Picking Locks For Sport, Not Sabotage
- Sacha Baron Cohen And Larry Charles Talk 'Bruno'
- Boston Unveils Five-Year School Restructuring Plan
- 'The Onion': Mocking All Who Deserve It Since 1988
- Senate Candidates Spar Over ‘Green’ Issues
- Mass. Unemployment Fund Running Out Of Money
- Does Boston Have Room For More Ice Cream?
- Woo! And it's @WBUR's 2nd most viewed article. OK, OK, back to work now, just exciting :)
- I know I yapped about this yesterday, but Andrea Shea's story on me for @WBUR went national on Here & Now: http://is.gd/4ZSjx !!
- wbur.org: Study: No Cost Savings With Electronic Medical Records http://www.wbur.org/2009/11/20/medical-records @WBUR
- RT: @mediaunbound Music Recs & Discovery on @OnPointRadio / @wbur. So what if @pandora_radio is B2C & we're B2B. More interest better 4 all!
-
Esperanza Rising
November 20, 2009
At Cutler Majestic Theatre -
Worcester Chamber Music Society "Baroque Fantasies"
November 20, 2009
At St John the Evangelist Church -
Talich Quartet
November 20, 2009
At Sweeney Concert Hall-Sage Hall -
Concert: Boston Artists Ensemble
November 20, 2009
At Peabody Essex Museum






inre: the
Genzyme products: Has someone looked at the separate INGREDIENTS — are they imported, perhaps ? What quality control does the company exercise ? Please DON’T LET FDA COME BACK CRYING POVERTY ! ‘WE’RE TOO POOR TO MONITOR WHAT WE’RE SUPPOSED TO MONITOR ‘ No pol on either side of aisle is going to deny FDA what $s it needs to protect Americans !
I moved from ARlington, MA a while ago. Was writing earlier for the Boston Phoenix … Still miss you.
Whatever happened to Chris Lydon ? f.